Hearing:
“Legislative Proposals to Enhance Capital Formation and Reduce Regulatory Burdens”
Subcommittee on Capital Markets and Government Sponsored Enterprises (Committee on Financial Services)
Wednesday, April 29, 2015 (2:00 PM)
HVC-210 CAPITOL
Washington, D.C.
Witnesses
Mr. Thomas C. Deas
Vice President and Treasurer, FMC Corporation, on behalf of the Coalition for Derivatives End-Users
Added
05/01/2015 at 06:33 PM
- Witness Statement
[PDF]
Added
05/01/2015 at 06:36 PM
- Witness Truth in Testimony
[PDF]
Added
05/01/2015 at 06:36 PM
Professor Theresa A. Gabaldon
Lyle T. Alverson Professor of Law, George Washington University
Added
05/01/2015 at 06:33 PM
- Witness Statement
[PDF]
Added
05/01/2015 at 06:36 PM
- Witness Truth in Testimony
[PDF]
Added
05/01/2015 at 06:36 PM
Ms. Gayle Hughes
Partner, Merion Investment Partners, on behalf of the Small Business Investor Alliance
Added
05/01/2015 at 06:33 PM
- Witness Statement
[PDF]
Added
05/01/2015 at 06:36 PM
- Witness Truth in Testimony
[PDF]
Added
05/01/2015 at 06:36 PM
Mr. Shane Kovacs
Executive Vice President, Chief Financial Officer and Head of Corporate Development,, PTC Therapeutics, Inc., on behalf of the Biotec
Added
05/01/2015 at 06:33 PM
- Witness Statement
[PDF]
Added
05/01/2015 at 06:36 PM
- Witness Truth in Testimony
[PDF]
Added
05/01/2015 at 06:36 PM
Mr. Thomas Quaadman
Vice President, Center for Capital Markets Competitiveness, U.S. Chamber of Commerce
Added
05/01/2015 at 06:33 PM
- Witness Statement
[PDF]
Added
05/01/2015 at 06:36 PM
- Witness Truth in Testimony
[PDF]
Added
05/01/2015 at 06:36 PM
First Published:
May 1, 2015 at 06:26 PM
Last Updated:
May 4, 2015 at 10:18 AM